Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1993-04-16
1999-04-06
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241981, 530300, 530350, 530399, A61K 3828
Patent
active
058914358
ABSTRACT:
The subject invention concerns compositions and methods useful for the prevention or amelioration of autoimmune diseases. Specifically exemplified are compositions and methods useful in immunizing to prevent insulin dependent diabetes. In a preferred embodiment, diabetes is prevented by the parenteral administration of a composition comprising specific antigenic peptides of insulin and further comprising incomplete Fruend's adjuvant.
REFERENCES:
patent: 4338306 (1982-07-01), Kitao et al.
patent: 4464363 (1984-08-01), Higuchi et al.
patent: 4650785 (1987-03-01), Toyoshima et al.
patent: 4789660 (1988-12-01), Enever et al.
patent: 5512447 (1996-04-01), Baekkeskov et al.
patent: 5691448 (1997-11-01), Baekkeskov et al.
Gilman, A. et al. (ed), Tha Pharmaceutical Basis of Therapeutics, 8th edition, pp. 1463-1484, 1990.
Atkinson, M. A. et al., J. clin. Invest. 92:1608-1616 (1993), Islet cell autoantigens in insulin-dependent diabetes.
Michael, J. G. et la., Immunological Invest. 18:1049-1054 (1989), The role of digestive enzymes in orally induced immune tolerance.
Paul, W.F. (ed.), Fundamental Immunology (1993), pp. 714-720 and 1067-1069. Raven Press, New York.
Cohen, I.R. et al., Dialog abstract 0902938, "Immunization to insulin generates antiidotypes that behave as antibodies to the insulin hormone receptor and cause diabetes mellitus".
Freytag, G. et al., Dialog abstract 542248, "Latent diabetes mellitus in guinea pigs induced by active immunization against bovine insulin".
Kloeppel, G. et al., Dialog abstract 1612079, Immune insulitis and manifest diabetes mellitus studies on the course of immune insulitis and the induction of diabetes mellitus in rabbits immunized with insulin.
Muir et al. Abstract entitled "Insulin-Specific Immunotherapy Ameliorates Diabetes in Nonobese Diabetic Mice" Journal of the American Diabetes Association, Supplement 1, (Program of the 52nd Annual Meeting of the American Diabetes Association, held Jun. 20-23, 1992).
Sokrut et al. (1991) Database WPI, Section Ch, Week 9201, Derwent Publications Ltd., London, Abstract AN 92-005453 and SU1624511.
Melez, K.A. et al., "Immune Abnormalities in the Diabetic New Zealand Obese (NZO) Mouse: Insulin Treatment Partially Suppresses Splenic Hyperactivity Measured by Flow Cytometric Analysis"; Clinical Immunology and Immunopathology (1985) 36, 110-119.
Panicali and Paoletti, "Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus"; Proc. Natl. Acad. Sci. USA (1982) 79, 4927-4931.
Ziegler, Anette G., Ralph Ziegler, Pnin Varki, Richard A. Jackson, J. Stuart Soeldner, and George S. Eisenbarth (1989) "Life-Table Analysis of Progression to Diabetes of Anti-Insulin Autoantibody-Positive Relatives of Individuals With Type 1 Diabetes" Diabetes 38:1320-1325.
Vardi, P., A.G. Ziegler, J.H. Mathews, S. Dib, R.J. Keller, A.T. Ricker, J.I. Wolfsdorf, R.D. Herskowitz, A. Rabizadeh, G.S. Eisenbarth, J.S. Soeldner (1988) "Concentration of InsulinAutoantibodies at Onset of Type 1 Diabetes: Inverse Log-Linear Correlation with Age" Diabetes Care 11(9):736-739.
Atkinson, Mark A., Noel K. Maclaren, and Roberto Luchetta (1990) "Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy" Diabetes 39:933-937.
Steiner et al. (1989) "Chemistry and Biosynthesis of Pancreatic Protein Hormones," In Endocrinology, DeGroot et al., Eds., W.B. Saunder Company, pp. 1263-1289.
Palmer, et al. (1983) "Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment," Science, vol. 222:1337-1339.
Aaen et al. (1990) "Dependence of Antigen Expression on Functional State of B-Cells," Diabetes, vol. 39:697-701.
Kampe et al., "High-Glucose Stimulation of 64,000-M.sub.r Islet Cell Autoantigen Expression," (1989) Diabetes, vol. 38:1326-1328.
Jacob et al., "Prevention of Diabetes in Nonobese Diabetic Mice by Tumor Necrosis Factor (TNF): Similarities between TNF-a and Interleukin 1," (1990) Proc. Natl. Acad. Sci. USA, vol. 87:968-972.
Sadelain et al., "Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy," (1990) Diabetes, vol. 39:583-589.
Like et al., Influence of Environmental Viral Agents on Frequncy and Tempo of Diabetes Mellitus in BB/Wor Rats, (1991) Diabetes, vol. 40:259-262.
Steinman, Lawrence (1990), "Development of Antigen-specific Therapies for Autoimmune Disease," Mol. Biol. Med. 7:333-339.
Offner, H., G.A. hashim, A.A. Vandenbark, "T Cell Receptor Peptide Therapy Triggers Autoregulation of Experimental Encephalomyclitis" (1991) Science, vol. 251:430-432.
Kim, C., K.A. Siminovitch, A. Orchi, "Reduction of Lupus, nephritis in MRL/lpr Mice by a Bacterial Superantigen Treatment," (1991) J. Exp. med. 174:1431-1437.
Silverman, et al., "Enterically induced regulation of Systemic Immune Responses," vol. 131:2651-2661.
Peng, H.J., M.W. Turner, S. Strobel, "The Generation Of a Tolerogen After the Ingestion of Ovalbumin is Time-dependent and Unrelated to Serum levels of Immunoreactive Antigen," (1990) Clin. Exp. Immunol, vol. 81:510-515.
Michael, J. Gabriel, "The Role of Digestive Enzymes in orally Induced Immune Tolerance," (1989) Immune Invest. 18:1049-1054.
Kitamura et al., "Contrasuppressor Cells That Break Oral Tolerance Are Antigen-Specific T Cells Distinct From T helper (L3T4.sup.+), T Suppressor (Lyt-2.sup.+), and B Cells," (1987) J. Immunol. 139:3251-3259.
Michalek et al., "Lipopolysaccharide (LPS) Regulation Of The Immune Response: LPS Influence On Oral Tolerance Induction," (1982) The Journal of Immunology, vol. 128:1992-1998.
Mowat, A.M. et al., "Divergent Effects of Bacterial Lipopolysaccharide on Immunity to Orally Administered protein and Particulate Antigens in Mice," (1986) Immunology, vol. 58:677-683.
Nagler-Anderson, Cathryn et al., "Suppression of Type II Collagen-induced Arthritis by Intragastric Administration of Soluble Type II Collagen," (1986) Proc. Natl. Acad. Sci. USA, vol. 83:7443-7446.
Gesualdo, Loreto et al., "Defective Oral Tolerance Promotes Nephritogenesis In Experimental IgA Nephropathy Induced By oral Immunization," (1990) J. Immunol. 145:3684-3691.
Miller, et al., "Heterogeneity of Oral Tolerance Defects in Autoimmune Mice," (1984) Clin. Immunol. Immunopathol. 31:231-240.
Zhang et al., "Suppression of Diabetes in Nonobese Diabetic Mice by Oral Administration of Porcine Insulin," (1991) Proc. Natl. Acad. Sci. USA, vol. 88:10252-10256.
W. F. Paul (ed), Fundamental Immunology, 3rd edition (1993), pp. 1067-1069.
Paoletti, E., et al., P.N.A.S. (USA) 81:193-197 (Jan., 1984), "Construction of live vaccines using genetically engineered poxviruses . . . ".
Robbins Pathological Basis of Disease(R.S. Cotran, et al., eds.), 4th edition (1989), pp. 994-1001.
Maclaren Noel K.
Muir Andrew
Cunningham Thomas M.
Research Corporation Technologies Inc.
LandOfFree
Methods and compositions for delaying or preventing the onset of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for delaying or preventing the onset of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for delaying or preventing the onset of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1368660